A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma
Clinical trial NCT02194699 · COMPLETED
Trial details
- NCT number
- NCT02194699
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-30
- Primary completion
- 2017-05-10
- Enrollment
- 856
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.